Document is current
Any future updates will be listed below
-
Authors
Atkinson, Carolyn
Lombardi, Lorenzo
Lang, Meredith
Keesey, Rodolfo
Hawthorn, Rachel
Seitz, Zachary
Leuthardt, Eric C.
Brunner, Peter
Seáñez, Ismael
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (K01-NS127936, K01-NS127936, K01-NS127936, K01-NS127936, K01-NS127936, K01-NS127936, K01-NS127936)
National Institute of Child Health and Human Development (K12-HD073945, K12-HD073945, K12-HD073945, K12-HD073945, K12-HD073945)
National Institutes of Health (U24-NS109103, U24-NS109103)
National Institute of Biomedical Imaging and Bioengineering (P41-EB018783, P41-EB018783)
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 7 April 2025
First Online: 25 April 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and has been approved by Washington University in St. Louis’ Institutional Review Board (IRB ID 202105168). All participants signed a written informed consent prior to the study and received financial compensation for their participation.
: Not applicable.
: E.C.L. holds various patents in relation to the present work and is a founder and shareholder of Neurolutions, Inc., a company developing EEG technologies for stroke. All other authors declare no competing interests.
